Teladoc Health, Inc. (0LDR.L)
USD 6.86
(-3.12%)
USD 6.86
(-3.12%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.58 Billion USD | 0.52% |
| 2022 | 1.57 Billion USD | 24.13% |
| 2021 | 1.26 Billion USD | -10.91% |
| 2020 | 1.42 Billion USD | 205.7% |
| 2019 | 465.4 Million USD | 12.23% |
| 2018 | 414.68 Million USD | 99.97% |
| 2017 | 207.37 Million USD | 388.8% |
| 2016 | 42.42 Million USD | 68.17% |
| 2015 | 25.22 Million USD | 0.12% |
| 2014 | 25.19 Million USD | 739.87% |
| 2013 | 3 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 1.57 Billion USD | 0.09% |
| 2024 Q1 | 1.53 Billion USD | 0.06% |
| 2024 Q2 | 989.68 Million USD | -35.72% |
| 2023 Q3 | 1.57 Billion USD | -0.1% |
| 2023 Q4 | 1.58 Billion USD | 0.59% |
| 2023 FY | 1.58 Billion USD | 0.52% |
| 2023 Q1 | 1.57 Billion USD | -0.08% |
| 2023 Q2 | 1.57 Billion USD | 0.11% |
| 2022 Q2 | 1.57 Billion USD | 0.31% |
| 2022 Q1 | 1.57 Billion USD | 24.1% |
| 2022 Q4 | 1.57 Billion USD | -0.14% |
| 2022 FY | 1.57 Billion USD | 24.13% |
| 2022 Q3 | 1.57 Billion USD | -0.15% |
| 2021 Q4 | 1.26 Billion USD | 1.06% |
| 2021 Q2 | 1.23 Billion USD | -11.17% |
| 2021 Q3 | 1.25 Billion USD | 1.34% |
| 2021 FY | 1.26 Billion USD | -10.91% |
| 2021 Q1 | 1.39 Billion USD | -2.08% |
| 2020 Q4 | 1.42 Billion USD | 44.61% |
| 2020 FY | 1.42 Billion USD | 205.7% |
| 2020 Q3 | 983.81 Million USD | 0.79% |
| 2020 Q2 | 976.11 Million USD | 104.79% |
| 2020 Q1 | 476.65 Million USD | 2.42% |
| 2019 Q3 | 459.61 Million USD | 1.33% |
| 2019 Q1 | 443.82 Million USD | 7.03% |
| 2019 Q2 | 453.58 Million USD | 2.2% |
| 2019 FY | 465.4 Million USD | 12.23% |
| 2019 Q4 | 465.4 Million USD | 1.26% |
| 2018 Q2 | 402.75 Million USD | 91.39% |
| 2018 Q3 | 408.65 Million USD | 1.46% |
| 2018 FY | 414.68 Million USD | 99.97% |
| 2018 Q4 | 414.68 Million USD | 1.48% |
| 2018 Q1 | 210.43 Million USD | 1.48% |
| 2017 Q2 | 243.83 Million USD | 474.62% |
| 2017 Q1 | 42.43 Million USD | 0.02% |
| 2017 FY | 207.37 Million USD | 388.8% |
| 2017 Q4 | 207.37 Million USD | -44.15% |
| 2017 Q3 | 371.33 Million USD | 52.29% |
| 2016 Q1 | 24.95 Million USD | -1.07% |
| 2016 Q2 | 27.13 Million USD | 8.74% |
| 2016 FY | 42.42 Million USD | 68.17% |
| 2016 Q4 | 42.42 Million USD | -0.11% |
| 2016 Q3 | 42.46 Million USD | 56.5% |
| 2015 Q4 | 25.22 Million USD | -2.46% |
| 2015 Q3 | 25.86 Million USD | -17.65% |
| 2015 Q2 | 31.4 Million USD | 26.13% |
| 2015 Q1 | 24.9 Million USD | -1.17% |
| 2015 FY | 25.22 Million USD | 0.12% |
| 2014 Q4 | 25.19 Million USD | 0.0% |
| 2014 FY | 25.19 Million USD | 739.87% |
| 2014 Q1 | - USD | 0.0% |
| 2013 FY | 3 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -77085.212% |
| Accuray Incorporated | 164.4 Million USD | -861.998% |
| Align Technology, Inc. | 96.96 Million USD | -1530.976% |
| Elevance Health Inc. | 23.24 Billion USD | 93.197% |
| AxoGen, Inc. | 46.6 Million USD | -3293.612% |
| Boston Scientific Corporation | 8.56 Billion USD | 81.537% |
| CVS Health Corporation | 74.67 Billion USD | 97.882% |
| Cardinal Health, Inc. | 4.58 Billion USD | 65.491% |
| Centene Corporation | 17.69 Billion USD | 91.064% |
| DaVita Inc. | 8.05 Billion USD | 80.357% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 95.682% |
| Hologic, Inc. | 2.49 Billion USD | 36.666% |
| Humana Inc. | 10.21 Billion USD | 84.515% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -153.904% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | 60.995% |
| Masimo Corporation | 871.7 Million USD | -81.43% |
| McKesson Corporation | 5.45 Billion USD | 70.987% |
| Patterson Companies, Inc. | 328.91 Million USD | -380.837% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | 64.138% |
| ResMed Inc. | 697.31 Million USD | -126.803% |
| Henry Schein, Inc. | 1.93 Billion USD | 18.183% |
| Universal Health Services, Inc. | 4.71 Billion USD | 66.466% |
| Veeva Systems Inc. | 46.44 Million USD | -3305.45% |
| Baxter International Inc. | 11.06 Billion USD | 85.706% |
| Becton, Dickinson and Company | 14.73 Billion USD | 89.269% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 2026.34% |
| Danaher Corporation | 17.66 Billion USD | 91.045% |
| Stryker Corporation | 10.9 Billion USD | 85.492% |
| Medtronic plc | 23.87 Billion USD | 93.376% |